These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 12615729

  • 1. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H, Shannon P, Lau N, Wu X, Roncari L, Baldwin RL, Takebayashi H, Nagy A, Gutmann DH, Guha A.
    Cancer Res; 2003 Mar 01; 63(5):1106-13. PubMed ID: 12615729
    [Abstract] [Full Text] [Related]

  • 2. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
    Ding H, Roncari L, Shannon P, Wu X, Lau N, Karaskova J, Gutmann DH, Squire JA, Nagy A, Guha A.
    Cancer Res; 2001 May 01; 61(9):3826-36. PubMed ID: 11325859
    [Abstract] [Full Text] [Related]

  • 3. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.
    Casanova ML, Larcher F, Casanova B, Murillas R, Fernández-Aceñero MJ, Villanueva C, Martínez-Palacio J, Ullrich A, Conti CJ, Jorcano JL.
    Cancer Res; 2002 Jun 15; 62(12):3402-7. PubMed ID: 12067982
    [Abstract] [Full Text] [Related]

  • 4. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice.
    Weissenberger J, Steinbach JP, Malin G, Spada S, Rülicke T, Aguzzi A.
    Oncogene; 1997 May 01; 14(17):2005-13. PubMed ID: 9160879
    [Abstract] [Full Text] [Related]

  • 5. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C.
    Neurol India; 2009 May 01; 57(5):559-66. PubMed ID: 19934553
    [Abstract] [Full Text] [Related]

  • 6. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
    Huang ZY, Baldwin RL, Hedrick NM, Gutmann DH.
    Oncogene; 2002 Feb 21; 21(9):1325-34. PubMed ID: 11857076
    [Abstract] [Full Text] [Related]

  • 7. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC.
    Genes Dev; 2001 Aug 01; 15(15):1913-25. PubMed ID: 11485986
    [Abstract] [Full Text] [Related]

  • 8. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
    Su W, Xing R, Guha A, Gutmann DH, Sherman LS.
    Glia; 2007 May 01; 55(7):723-33. PubMed ID: 17348023
    [Abstract] [Full Text] [Related]

  • 9. Genetic determinants of malignancy in a mouse model for oligodendroglioma.
    Weiss WA, Burns MJ, Hackett C, Aldape K, Hill JR, Kuriyama H, Kuriyama N, Milshteyn N, Roberts T, Wendland MF, DePinho R, Israel MA.
    Cancer Res; 2003 Apr 01; 63(7):1589-95. PubMed ID: 12670909
    [Abstract] [Full Text] [Related]

  • 10. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.
    Dlugosz AA, Hansen L, Cheng C, Alexander N, Denning MF, Threadgill DW, Magnuson T, Coffey RJ, Yuspa SH.
    Cancer Res; 1997 Aug 01; 57(15):3180-8. PubMed ID: 9242447
    [Abstract] [Full Text] [Related]

  • 11. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.
    Holland EC, Li Y, Celestino J, Dai C, Schaefer L, Sawaya RA, Fuller GN.
    Am J Pathol; 2000 Sep 01; 157(3):1031-7. PubMed ID: 10980141
    [Abstract] [Full Text] [Related]

  • 12. Brain tumors in S100beta-v-erbB transgenic rats.
    Ohgaki H, Kita D, Favereaux A, Huang H, Homma T, Dessen P, Weiss WA, Kleihues P, Heppner FL.
    J Neuropathol Exp Neurol; 2006 Dec 01; 65(12):1111-7. PubMed ID: 17146284
    [Abstract] [Full Text] [Related]

  • 13. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
    Wang XJ, Greenhalgh DA, Roop DR.
    Mol Carcinog; 2000 Mar 01; 27(3):200-9. PubMed ID: 10708482
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
    Cheng J, Huang H, Zhang ZT, Shapiro E, Pellicer A, Sun TT, Wu XR.
    Cancer Res; 2002 Jul 15; 62(14):4157-63. PubMed ID: 12124355
    [Abstract] [Full Text] [Related]

  • 15. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
    Jhappan C, Takayama H, Dickson RB, Merlino G.
    Cell Growth Differ; 1994 Apr 15; 5(4):385-94. PubMed ID: 8043512
    [Abstract] [Full Text] [Related]

  • 16. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA, Orian JM, Gonzales MF, Tan SS, Alexander B, Mikoshiba K, Kaye AH.
    Cancer Res; 1995 Oct 01; 55(19):4302-10. PubMed ID: 7671240
    [Abstract] [Full Text] [Related]

  • 17. Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model.
    Shannon P, Sabha N, Lau N, Kamnasaran D, Gutmann DH, Guha A.
    Am J Pathol; 2005 Sep 01; 167(3):859-67. PubMed ID: 16127163
    [Abstract] [Full Text] [Related]

  • 18. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR.
    Clin Cancer Res; 2006 Sep 01; 12(17):5064-73. PubMed ID: 16951222
    [Abstract] [Full Text] [Related]

  • 19. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA.
    Cancer Res; 2006 Jan 15; 66(2):867-74. PubMed ID: 16424019
    [Abstract] [Full Text] [Related]

  • 20. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
    Tanaka KF, Takebayashi H, Yamazaki Y, Ono K, Naruse M, Iwasato T, Itohara S, Kato H, Ikenaka K.
    Glia; 2007 Apr 15; 55(6):617-31. PubMed ID: 17299771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.